In order to justify whether CSBTA could inhibit breast cancer-induced osteoclast differentiation through its anticancer effects, here we compared the anticancer effects of CSBTA on the mRNA levels of Bax, Bcl-2, p53 and Caspase-3 in both breast cancer cell lines. This evidence concerns the gene TP53 and breast carcinoma.